519 related articles for article (PubMed ID: 12553888)
21. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
22. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
23. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
Chandran S; Ravi P; Saha RN
Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
[TBL] [Abstract][Full Text] [Related]
24. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
Shah SU; Shah KU; Rehman A; Khan GM
Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
[TBL] [Abstract][Full Text] [Related]
25. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
26. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
Boyapally H; Nukala RK; Douroumis D
Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
[TBL] [Abstract][Full Text] [Related]
27. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug.
Khan GM; Zhu JB
J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903
[TBL] [Abstract][Full Text] [Related]
28. Formulation development and optimization of bilayer tablets of aceclofenac.
Dey S; Mahanti B; Khila S; Mazumder B; Gupta SD
Expert Opin Drug Deliv; 2012 Sep; 9(9):1041-50. PubMed ID: 22788786
[TBL] [Abstract][Full Text] [Related]
29. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
Wu B; Shun N; Wei X; Wu W
Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
[TBL] [Abstract][Full Text] [Related]
30. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
Varshosaz J; Tavakoli N; Kheirolahi F
AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
[TBL] [Abstract][Full Text] [Related]
31. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
Ebube NK; Jones AB
Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
[TBL] [Abstract][Full Text] [Related]
32. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
Saravanan M; Sri Nataraj K; Ganesh KS
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
[TBL] [Abstract][Full Text] [Related]
33. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
van der Weerd J; Kazarian SG
J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
[TBL] [Abstract][Full Text] [Related]
34. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
Ravi PR; Ganga S; Saha RN
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
[TBL] [Abstract][Full Text] [Related]
35. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
[TBL] [Abstract][Full Text] [Related]
36. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
[TBL] [Abstract][Full Text] [Related]
37. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.
Bravo SA; Lamas MC; Salomon CJ
Pharm Dev Technol; 2004; 9(1):75-83. PubMed ID: 15000468
[TBL] [Abstract][Full Text] [Related]
38. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets.
Velasco MV; Ford JL; Rowe P; Rajabi-Siahboomi AR
J Control Release; 1999 Jan; 57(1):75-85. PubMed ID: 9863041
[TBL] [Abstract][Full Text] [Related]
39. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
[TBL] [Abstract][Full Text] [Related]
40. In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets.
Liu CH; Kao YH; Chen SC; Sokoloski TD; Sheu MT
J Pharm Pharmacol; 1995 May; 47(5):360-4. PubMed ID: 7494183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
